Diagnostic Modalities and Nodal Staging in High-Risk Cutaneous Squamous Cell Carcinoma
JAMA Dermatology 10.1001/jamadermatol.2026.0803April 22, 2026 at 11:00 AM EDT
What is the diagnostic performance of physical examination, ultrasonography, and computed tomography (CT) for baseline nodal staging in high-risk cutaneous squamous cell carcinoma (cSCC), and does a patient’s immune status affect performance?This multicenter diagnostic study including 155 patients found that ultrasonography and CT outperformed physical examination and showed high concordance in detecting nodal staging in high-risk cSCC, with overall sensitivity of 63.6% for ultrasonography, 54.5% for CT, and 8.3% for physical examination. All metastatic cases were correctly detected in immunocompetent patients by CT and ultrasonography; however, sensitivity dropped sharply in immunosuppressed individuals, where most nodal metastases emerged within 3 months despite negative baseline imaging.Ultrasonography and CT may be superior to physical examination for early detection of nodal metastases in high-risk cSCC, but their limited performance in patients with immunosuppression warrants tailored guideline recommendations.
Link to the article in your story
We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)
Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
Need more information? Contact us.